Biological monitoring of exposure: Trends and key developments

Journal of Occupational Health

Volumn 47, Issue 1, 2005, Pages 22-48

  Jakubowski, Marek ^a   Trzcinka Ochocka, Malgorzata ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Biological monitoring; Environmental exposure; Occupational exposure

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; HEAVY METAL; PESTICIDE; POLYCYCLIC AROMATIC HYDROCARBON; VOLATILE ORGANIC COMPOUND; XENOBIOTIC AGENT;

BIOLOGICAL MONITORING; DNA ADDUCT; DOSE RESPONSE; DRUG EXPOSURE; ENVIRONMENTAL HEALTH; EUROPE; HEALTH HAZARD; HEALTH SURVEY; INDUSTRIAL HYGIENE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; ORGANIC POLLUTION; POLICY; REVIEW; UNITED STATES; URINALYSIS;

BIOLOGICAL MARKERS; ENVIRONMENTAL EXPOSURE; EUROPE; HUMANS; OCCUPATIONAL EXPOSURE; UNITED STATES;

EID: 14544306923     PISSN: 13419145     EISSN: None     Source Type: Journal    
DOI: 10.1539/joh.47.22     Document Type: Review

References (159)

1. WHO. Air Quality Guidelines for Europe. Second Edition. WHO Regional Publications, European Series, No 91. Copenhagen, 2000.
2. WHO. Guidelines for Drinking-water Quality. Second Edition. Vol. 1. Geneva, 1993.
3. ACGIH. TLVs and BEIs Based on the Documentation of the Threshold Limit values for Chemical Substances and Physical Agents & Biological Exposure Indices. Cincinnati: OH, 2003.
4. DFG Deutsche Forschungsgemeinschaft. List of MAK and BAT Values. Wiley-VCH Verlag, Weinheim, 2003.
5. Teisinger J, Skramovsky S, Srbova J. Investigations of Biological Media in Industrial Toxicology. Prague: Statni Zdrovotni Nakladitelstvi, 1956: 127 (in Czech)
6. nd edn. New York: John Wiley and Sons, Inc., 1959: 452
7. WM Draper: Biological Monitoring: Exquisite research probes, risk assessment, and routine exposure measurement. Anal Chem 73, 2745-2760 (2001)
8. P Hoet and V Haufroid: Biological monitoring: state of art. Occup Environ Med 54, 361-366 (1997)
9. MS Morgan: The biological exposure indices: A key component of protecting workers from toxic chemicals. Environ Health Perspect 105, Suppl. 1, 105-114 (1977)
10. A Aitio: Biomarkers and their use in occupational medicine. Scand J Work Environ Health 25, 521-528 (1999)
11. R Heinrich-Ramm, M Jakubowski, B Heinzow, J Molin Christensen, E Olsen and O Hertel: Biological monitoring for exposure to volatile organic compounds (IUPAC Recommendations 2000). Pure Appl Chem 72, 385-436 (2000)
12. A Sato: Confounding factors in biological monitoring of exposure to organic solvents. Int Arch Occup Environ Health 65, S61-S67 (1993)
13. MS Morgan and KH Schaller: An analysis of criteria for biological limit values developed in Germany and in the United States. Int Arch Occup Environ Health 72, 195-102 (1999)
14. Piotrowski JK. Exposure Tests for Organic Compounds in Industrial Toxicology. Cincinnati: U.S. Department of Health, Education and Welfare, 1977: 137.
15. WHO. Biological Monitoring of Chemical Exposure in the Workplace. Volume 1. Geneva, 1996: 300.
16. WHO. Biological Monitoring of Chemical Exposure in the Workplace. Volume 2. Geneva, 1996: 203.
17. Que Hee SS. Biological Monitoring. An Introduction. Van Nostrand Reinhold, N.Y.
18. Lauwerys RR, Hoet P. Industrial Chemical Exposure. Guidelines for Biological Monitoring. London, N.Y., Washington D.C.: Lewis Publishers, Boca Raton, 1993: 318.
19. Lauwerys RR, Hoet P: Industrial Chemical Exposure. Guidelines for Biological Monitoring. Third edition. London, N.Y., Washington D.C.: Lewis Publishers, Boca Raton, 2001: 638.
20. ACGIH. Documentation of the TLVs and BEIs with other Worldwide Occupational Exposure Values. Cincinnati: OH, 2003.
21. DFG. Deutsche Forschungsgemeinschaft: Biological Exposure Values for Occupational Toxicants and Carcinogens. Critical data Evaluation for BAT and EKA Values. Volume 1. (Henschler D., Lehnert G., eds). VCH Verlag,Weinheim, 1994: 235.
22. DFG. Deutsche Forschungsgemeinschaft: Biological Exposure Values for Occupational Toxicants and Carcinogens. Critical data Evaluation for BAT and EKA Values. Volume 2. (Greim H, Lehnert G, eds). VCH Verlag, Weinheim, 1995: 221
23. DFG. Deutsche Forschungsgemeinschaft: Biological Exposure Values for Occupational Toxicants and Carcinogens. Critical data Evaluation for BAT and EKA Values. Volume 3. (Greim H., Lehnert G., eds). VCH Verlag,Weinheim, 1994: 264.
24. IPCS. Biomarkers and Risk Assessment: Concepts and Principles. Environmental Health Criteria. Vol. 155. World Health Organization, Geneva, 1993.
25. Opinion of the European Group on Ethics in Science and New technologies to the European Commission: Ethical Aspects of genetic testing in the Workplace. No18. Final July 2003.
26. SCOEL. Methodology for the derivation of occupational exposure limits: Key documentation. European Commission, Directorate-General for Employment, Industrial Relations and Social Affairs, 1999.
27. Health & Safety Laboratory. Guidance on Laboratory Techniques in Occupational Medicine. Ninth Edition, 2002.
28. HK Wilson: Biological monitoring values for occupational exposure: a United Kingdom perspective. Int Arch Occup Environ Health, 72, 274-278, (1999).
29. Työterveyslaitos. Kemikaalialtistumisen Biomonitorrointi. Näyytteenotto-ohjeet, 2003.
30. S Ghittori, A Alessio, L Maestri, S Negri, M Sgroi and P Zadra: Schede informative per il monitoraggio biologico. Giornale Italiano di medicina del Lavoro ed Ergonomia 24, 3 Suppl (2002)
31. CIOP. Miȩdzyresortowa Komisja ds. Najwyiszych Dopuszczalnych Stȩżeń i Natȩżeń Czynników Szkodliwych dla Zdrowia w Środowisku Pracy. Czynniki Szkodliwe w Środowisku Pracy, wartości dopuszczalne. CIOP, Warszawa 2003.
32. A Zober and W Will: Biological monitoring and risk assessment in occupational settings. Int Arch Occup Environ health 68, 389-393 (1996)
33. R Lauwerys, A Bernard, JP Buchet and H Roels: Assessment of the health impact of environmental exposure to cadmium: contribution of the epidemiological studies carried out in Belgium. Environmental Research 62, 200-206 (1993)
34. A Schütz and CG Elinder: Low-level exposure to cadmium and early kidney damage; the OSCAR study. Occup Environ Med 57, 668-672 (2000)
35. CW Noonan, SM Sarasua, D Campagna, SJ Kathman, JA Lybarger and PW Mueller: Effects of exposure to low levels of environmental cadmium on renal biomarkers. Environ Health Perspect 110, 151-155, (2002)
36. M Trzcinka-Ochocka, M Jakubowski, G Rainiewska, T Hałatek and A Gazewski: The effects of environmental cadmium exposure on kidney function: the possible influence of age. Environ Res 95, 143-150 (2004)
37. L Järup, M Berglund, CG Elinder, G Nordberg and M Vahter: Health effects of cadmium exposure-a review of the literature and a risk estimate. Scand J work Environ Health 24, (suppl 1) 1-51 (1998)
38. IPCS. Inorganic Lead. Environmental Health Criteria. Geneva: WHO, 1995.
39. Centers for Disease Control. Preventing Lead Poisoning in Young Children. 1991.
40. RL Canfield, CR Henderson, DA Cory-Slechta, C Cox, TA Jusko and B Lanphear: Intellectual impairment in children with blood lead concentrations below 10 μg per decilitre. N Engl J Med 348, 1517-1526 (2003)
41. MJ Trepka, J Heinrich, Ch Krause: The internal burden of lead among children in smelter town-a small area analysis. Environ Res 72, 118-130 (1997).
42. M Cikrt, Z Smerhovsky and K Blaha: Biological monitoring of child lead exposure in the Czech Republic. Environ Health Perspect 105, 406-411 (1997)
43. M Berglund, B Lind, E Lannero and M Vahter: A pilot study of lead and cadmium exposure in young children in Stockholm, Sweden: Methodological considerations using capillary blood microsampling. Arch Environ Contam Toxicol 27, 281-287 (1994)
44. M Jakubowski, M Trzcinka-Ochocka, G Rainiewska, JM Christensen and A Starek: Blood lead in the general population in Poland. Int Arch Occup Environ Health 68, 193-198 (1996)
45. Toxicological Profile. U.S.Department of Health and Human Services. Toxicological Profile for Lead (Update). July, 1999.
46. IPCS. Methylmercury. Environmental Health Criteria, Vol. 101. WHO, Geneva, 1990.
47. K Murata, E Budtz-Jorgernsen and P Grandjean: Benchmark dose calculation for methylmercury-associated delays on evoked potential latencies in two cohorts of children. Risk Analysis 22, 465-474 (2002).
48. E Budtz-Jorgensen, P Grandjean, N Keiding, RF White and P Weiche: Benchmark dose calculations of methylmercury-associated neurobehavioral deficits. Toxicology Letters, 112-113, 193-199 (2000).
49. KS Crump, T Kjellstrom, AM Shipp, A Silvers and A Stewart: Influence of prenatal mercury exposure upon scholastic and psychological test performance: benchmark analysis of a New Zealand cohort. Risk Analysis 18, 701-713 (1998)
50. G Drasch, E Wanghofer and G Roider: Are blood, urine, hair, and muscle valid biomonitors for the internal burden of men with the heavy metals: mercury, lead and cadmium? Trace Elements and Electrolytes 14, 116-123 (1997)
51. P Grandjean, P Weihe and PJ Jorgensen: Impact of maternal seafood diet on foetal exposure to mercury, selenium and lead. Arch Environ Health 47, 185-195 (1992)
52. A Oskarsson, A Schultz and S Skerfving: Total and inorganic mercury in breast milk in relation to fish consumption and amalgam in lactating women. Arch Environ Health 51, 234-241 (1996)
53. A Renzoni, F Zino and E Franchi: Mercury levels along the food chain and risk for exposed populations. Environ Res 77, 68-72 (1998)
54. U Ewers, C Krause, C Schulz and M Wilhelm: Reference values and human biological monitoring values for environmental toxins. Report on the work and recommendations of the Commission on Human Biological Monitoring of the German Federal Environmental Agency. Int Arch Occup Environ Health 72, 255-260 (1999)
55. M Wilhelm, U Ewers and Ch Schultz: Revised and new reference values for some trace elements in blood and urine for human biomonitoring in environmental medicine. Int J Hyg Environ Health 207, 69-73 (2004)
56. A Duggan, G Charnley, W Chen, A Chukwudebe, R Hawk and RI Krieger: Di-alkyl phosphate biomonitoring data: assessing cumulative exposure to organophosphate pesticides. Reg Toxicol Pharmacol 37, 382-393 (2003)
57. CDC. Second National Report on Human Exposure to Environmental Chemicals. National Center for Environmental Health. Publication No 03-0572, October 2003. Web site:www.cdc.gov/exposure report.
58. KH Schaller and J Angerer: Biomonitoring in der Umweltmedizin. Umweltmed Forsch Prax 3, 168-175 (1998) (in German)
59. Christensen JM. Human exposure to metals. Factors influencing Interpretation of biomonitoring results. Copenhagen: National Institute of Occupational Health, 1995.
60. L Alessio: Reference values for the study of low doses of metals. Int Arch Occup Environ Health 65, S23-S27 (1993)
61. O Vesterberg, L Alessio and D Brune: International project for producing reference values for concentrations of trace elements in human blood and urine -TRACY. Scand J Work Environ Health suppl. 1, 19-26 (1993)
62. R Cornelis, B Heinzow and RFM Herber: Sample collection guidelines for trace elements in blood and urine. Pure Appl Chem, 67, 1575-1568 (1995)
63. K Schmidt, P Lederer, T Goen, K H Schaller, H Strebl, A Weber, J Angerer and G Lehnert: Internal exposure to hazardous substances of persons from various continents: investigations on exposure to different organochlorine compounds. Int Arch Occup Environ Health 69, 399-406 (1997)
64. FRX Van Leeuwen and R Malisch: Results of the third round of the WHO-coordinated study on the levels of PCBs, PCDDs and PCFFs in human milk. Organohalogen Compounds 56, 311-316 (2002)
65. MD Gerhardsson, G Kazantzis and A Schutz: Evaluation of selected publications on reference values for lead in blood. Scand J Work Environ Health 31, 325-331 (1996)
66. W Wesołowski and JP Gromiec: Occupational exposure in Polish paint and lacquer industry. Int J Occup Med Environ Health 10, 79-88 (1997)
67. M Ikeda: Solvents in urine as exposure markers. Toxicology Letters 108, 99-106 (1999)
68. FJ Klocke and H Rahan: The arterial-alveolar inert gas difference in normal and emphysematous subjects as indicated by the analysis of urine. J Clin Invest 40, 286-294 (1961)
69. S Ghittori, M Imbriani, G Pezzagno and E Capodaglio: The urinary concentration of solvents as a biological indicator of exposure: Proposal for the biological equivalent exposure limit for nine solvents. Am Ind Hyg Assoc J 48, 786-790 (1987)
70. M Hakkola, L Saarinen and K Pekari: Exposure to gasoline vapor during offloading of tankers and railway wagons and biological multicompartment monitoring. J Occup Health 43, 287-290 (2001)
71. S Vainiotalo, K Pekari and A Aitio: Exposure to methyl tert-butyl ether and tert-amyl methyl ether from gasoline during tank lorry loading and its measurement using biological monitoring. Int Arch Occup Environ Health 71, 391-396 (1988)
72. L Saarinen, M Hakkola, K Pekari, K Lappalainen and A Aitio: Exposure of gasoline road-tanker drivers to methyl tert-butyl ether and methyl tert-amyl ether. Int Arch Occup Environ Health 71, 143-147 (1998)
73. T Kawai, K Mizunuma, T Yasugi, S Horiguchi and M Ikeda: Toluene in blood as a marker of choice for low-level exposure to toluene. Int Arch Occup Environ Health, 66: 309-315 (1994)
74. A Tageuchi, T Kawai and ZW Zhang: Toluene, xylenes and xylene isomers in urine as biological indicators of low-level exposure to each solvent; a comparative study. Int Arch Occup Environ Health 75, 387-393 (2002)
75. S Ghittori, G Saretto and M Imbriani: Biological monitoring of workers exposed to carbon tetrachloride vapor. Appl Occup Environ Hyg 9, 353-357 (1994)
76. S Fustinioni, R Giampiccolo, S Pulvirenti, M Buratti and A Colombi: Headspace solid-phase microextraction for the determination of benzene, toluene, ethylbenzene and xylenes in urine. J Chromatogr 723, 105-115 (1999)
77. S Fustistoni, M Buratti, R Giampiccolo, G Brambilla, V Foa and A Colombi: Comparison between blood and urinary toluene as biomarkers of exposure to toluene. Int Arch Occup Environ Health 73, 389-396 (2000)
78. IPCS. Environmental Health Criteria 202. Selected Non-heterocyclic Polycyclic Aromatic Hydrocarbons. Geneva: WHO, 1998.
79. MJ Ferreira, JP Buchet, JB Burrion, J Moro, L Cupers, JP Jacques and R Lauwerys: Determination of urinary thioethers, D-glucaric acid and mutagenicity after exposure to polycyclic aromatic hydrocarbons assessed by air monitoring and measurements of 1-hydroxypyrene in urine: A cross-sectional study in workers of coke and graphite-electrode-producing plants. Int Arch Occup Environ Health 65, 329-338 (1994)
80. M J Ferreira, S Tas, M Dell'Omo, G Goormans, J Buchet and R Lauwerys: Determinants of benzo[a]pyrene diol epoxide adducts to hemoglobin in workers exposed to polycyclic aromatic hydrocarbons. Occup Environ Med 51, 451-455 (1994)
81. C Reuterwall, L Aringer, CG Elinder, A Rannug, JO Levin and L Juringe: Assessment of genotoxic exposure in Swedish coke-oven work by different methods of biological monitoring. Scand J Work Environ Health 17, 123-132 (1991)
82. G Becher and A Bjorseth: Determination of exposure to polycyclic aromatic hydrocarbons by analysis of human urine. Cancer Lett 17, 301-311 (1983)
83. P Venier, E Clonfero and D Cottica: Mutagenic activity and polycyclic aromatic hydrocarbon level in urine of workers exposed to coal tar pitch volatiles in anode plant. Carcinogenesis 6, 749-752 (1985)
84. A Haugen, G Becher and C Bemestad: Determination of polycyclic aromatic hydrocarbons in the urine, benzo[a]pyrene diol epoxide-DNA adducts in lymphocytes, and antibodies to the adducts in sera from coke-oven workers exposed to measured amounts of polycyclic aromatic hydrocarbons in the work atmosphere. Cancer Res 46, 4178-4183 (1986)
85. FJ Jongenellen, RP Bos and RBM Anzion: Biological monitoring of polycyclic aromatic hydrocarbons. Scand J Work Environ Health 12, 137-143 (1986).
86. PJ Boogaard and NJ van Sittert: Exposure to Polycyclic aromatic hydrocarbons in petrochemical industries by measurement of urinary 1-hydroxypyrene. Occup Environ Med 51, 250-258 (1994)
87. JGM van Rooij, MM Bodelier-Bade, PM, J Hopmans and FJ Jongeneelen: Reduction of urinary 1-hydroxypyrene excretion in coke-oven workers exposed to Polycyclic aromatic hydrocarbons due to improved hygienic skin protective measures. Ann Occup Hyg 38, 247-256 (1994)
88. R Quinlan, G Kowalczyk, K Gardiner and I Calvert: Exposure to polycyclic aromatic hydrocarbons in coal liquefaction workers: Impact of a workwear policy on excretion of urinary 1-hydroxypyrene. Occup Environ Med 52, 600-605 (1995)
89. FJ Jongeneelen: Biological exposure limit for occupational exposure to coal tar pitch volatiles in coke-ovens. Int Arch Occup Environ Health 63, 511-515 (1992)
90. JO Levin, M Rhen and E Sikström: Occupational PAH exposure: urinary 1-hydroxypyrene levels in coke-oven workers, aluminium smelter pot-room workers, roadpavers, and occupationally non-exposed persons in Sweden. Sci Total Environ 193, 169-177 (1995)
91. GM van Rooij, MM Bodelier- Bade and FJ Jongeneelen: Estimation of individual dermal and respiratory uptake of polycyclic aromatic hydrocarbons in12 coke-oven workers. Brit J Ind Med 50, 623-632 (1993)
92. EY Tjoe Ny, D Heedrik, H Kromhout and FJ Jongenellen: The relationship between polycyclic aromatic hydrocarbons in air and urine of workers in a Söderberg potroom. Adv Ind Environ Hyg 54, 277-284 (1993)
93. JP Buchet, M Ferreira and JB Burrion: Tumor markers in serum, polyamines and modified nucleosides in urine, and cytogenetic aberrations in lymphocytes of workers exposed to Polycyclic aromatic hydrocarbons. Am J Ind Med 27, 523-543 (1995)
94. FJ Jongenellen: Benchmark guideline for urinary 1-hydroxypyrene as biomarker of occupational exposure to polycyclic aromatic hydrocarbons. Ann Occup Hyg 45, 3-13 (2001)
95. E Clonfero, M Zordan and P Venier: Biological monitoring of human exposure to coal tar. Urinary excretion of total Polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagens in psoriatic patients. Int Arch Occup Environ Health 61, 363-368 (1989)
96. RM Santella, MG Nunes and R Blaskovicet: Quantification of polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagenicity in urine of coal tar-treated psoriasis patients and untreated volunteers. Cancer Epidemiol Biomarkers Prev 3, 137-140 (1994)
97. D Mielżyńska and M Snit: Urine mutagenicity in workers directly employed in coke production. Pol J Occup Med 5, 363-371 (1992)
98. DB Barr, JR Barr, WJ Driskell, RH Hill, DL Ashley, LL Needham, SL Head and EJ Sampson: Strategies for biological monitoring of exposure to contemporary-use pesticides. Toxicol Ind Health 15, 168-179 (1999)
99. Z Zhang, J Sun, S Chen, Y Wu and F He: Levels of exposure and biological monitoring of perythroids in sprayman. Brit J Ind Med 48, 82-86 (1991)
100. M Maroni, C Colosio, A Ferioli and A Fait: Biological monitoring of pesticide exposure: a review. Toxicology 143, 1-118 (2000)
101. C Aprea, C Colosio, T Mammone, C Minoia and M Maroni: Biological monitoring of pesticide exposure: a review of analytical methods. J Chromatogr B 769, 191-219 (2002)
102. R Bravo, WJ Driskell, RJ Whitehead, LL Needham and DB Barr: Quantification of dialkyl phosphate metabolites of organophosphate pesticides in human urine using GC-MS-MS with isotope internal standards. J Anal Tox 26, 245-252 (2002)
103. NJ Simcox, J Camp, D Kalman, A Stebbins, G Bellamy, I-Ch Lee and R Fenske: Farmworker exposure to organophosphorus pesticide residues during apple thinning in Central Washington State. Am Ind Hyg Assoc J 60, 752-761 (1999)
104. M Maroni and A Fait: Risk assessment and health surveillance of pesticide workers. Med Lav 89 (suppl 2), S81-S90 (1998)
105. A Tuomainen, J Kangas, J Liesivuori and A Manninen: Biological monitoring of deltamethrin exposure in greenhouses. Int Arch Occup Environ Health 69, 62-64 (1966)
106. G Leng, K-H Kühn and H Idel: Biological monitoring of perythroids in blood and perythroid metabolites in urine: applications and limitations. Sci Total Environ 199, 173-181 (1997)
107. SA Harris, PN Corey, AM Sass-Kortsak and JT Purdham: The development of a new method to estimate total daily dose of pesticides in professional turf applicators following multiple and varied exposures in occupational settings. Int Arch Occup Environ Health 74, 345-358 (2001)
108. WA Anwar: Biomarkers of exposure to pesticides. Environ Health Persp 105, Suppl 4, 801-806 (1997)
109. CL Curl, RA Fenske and K Elegethun: Organophosphorous pesticide exposure of urban and suburban preschool children with organic and conventional diets. Environ Health Persp 111, 377-382 (2003)
110. JL Adgate, DB Barr, CA Clayton, LA Eberly, NCG Freeman, PJ Lioy, LL Needham, ED Pellizarri, JJ Quackenboss, AM Roy and K Sexton: Measurement of children's exposure to pesticides: Analysis of urinary metabolite levels in a probability-based sample. Environ Health Persp 109, 583-589 (2001)
111. RA Fenske, L Chensheng, D Barr and L Needham: Children's exposure to chloropyrifos and parathion in an agricultural community in central Washington State. Environ Health Persp 110, 549-553 (2002)
112. C Aprea, M Strambli, MT Novelli, L Lunghini and N Bozzi: Biologic monitoring of exposure to organophosphorous pesticides in195 Italian children. Env Health Persp 108, 521-525 (2000)
113. RM Whyatt, DB Barr, E Camann, PL Kinney, JR Barr, HF Andrews, LA, Hoepner, R Garfinkel, Y Hazi, A Reyes, J Ramirez, Y Cosme and FP Parera: Contemporary-use pesticides in personal air samples during pregnancy and blood samples at delivery among urban monitory mothers and newborns. Environ Health Persp 111, 749-756 (2003)
114. C Loewenherz, RA Fenske, NJ Simcox, G Bellamy and D Kalman: Biological monitoring of organophosphorous pesticide exposure among children of agricultural workers in central Washington state. Environ Health Persp 105, 1344-1353 (1997)
115. Angerer J. Biological monitoring in Occupational and environmental medicine-The present state of the art and future prospects. In: DFG Biological Monitoring. Prospects in Occupational and Environmental Medicine. Wiley-VCH Verlag, Weinheim, 2002: 5-15.
116. HM Koch, J Hardt and J Angerer: Biological monitoring of exposure of the general population to the organophosphorous pesticides chlorpyrifos and chlorpyrifos-methyl by determination of their specific metabolite 3,5,6-trichloro-2-pyridinol. Int J Hyg Environ Health 204, 175-180 (2001)
117. RH Hill Jr., SE Baker, C Rubin, E Esteban, SL Bailey, DB Shealy and LL Needham: Pesticide residues in urine of adults living in the United States: reference range concentrations. Environ Res 71, 99-108 (1995)
118. E Zieglel, HJ Mason and J Baxter: Occupational exposure to cytotoxic drugs in two UK oncology wards. Occup Environ Med 59, 608-612 (2002)
119. AS Ensslin, R Huber, A Pethran, H Rommelt, R Schierl and U Kulka: Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: urinary excretion and cytogenetic studies. Int Arch Occup Environ Health 70, 205-208 (1997)
120. C Minoia, E Sabbioni, P Apostoli, L Alessio and E Capaodaglio: Trace elements reference values in tissue from inhabitants of European cummunity. A study of 46 elements in urine, blood and serum of Italian subjects. Sci Total Environ 95, 89-105 (1990)
121. PJM Sessink, KA Boer, APH Schefhals, RBM Anzion and RP Bos: Occupational exposure to antineoplastic agents at several departments in a hospital. Occup Environ Med 64, 105-112 (1992)
122. R Turci, C Sottani, A Ronchi and C Minoia: Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents. Toxicol Lett 134, 57-64 (2002)
123. P Apostoli and KH Schaller: Urinary beryllium-a suitable tool for assessing occupational and environmental beryllium exposure? Int Arch Occup Environ Health 74, 162-166 (2001)
124. KJ Nikula, DS Swafford and MD Hoover: Chronic garanulomatous pneumonia and lymphocytic responses induced by inhaled beryllium metal. Toxicol Path 25, 2-12 (1997)
125. T Kraus, TP Schramel, PKH Schaller, P Zöbelein, A Weber and J Angerer: Exposure assessment in the hard metal manufacturing industry with spezial regard to tungsten and its compounds. Occup Environ Med 58, 631-634 (2001)
126. C Minoia, R Turci, C Sottani, A Achiavi, L Perbellini, S Angeleri, F Draicchio and P Apostoli: Application of high performance liquid chromatography/tandem mass spectrometry in the environmental monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide. Rapid Commun Mass Spectr 12, 1485-1493 (1998)
127. DC Paschal, BG Ting, JL Pirkle, DT Miller and KL Caldwell: Trace metals in urine of United States residents: reference range concentrations. Environ Res 76, 53-59 (1998)
128. R Wegner, R Heinrich-Ramm and D Nowak: Lung function, biological monitoring, and biological effect monitoring of gemstone cutters exposed to beryls. Occup Environ Med 57, 133-139 (2000)
129. PB Farmer: DNA and protein adducts as markers of genotoxicity. Toxicol Lett 149, 3-9 (2004)
130. RJ Turesky and P Vouros: Formation and analysis of heterocyclic aromatic amine-DNA adducts in vitro and in vivo. J Chromatogr B 802, 155-166 (2004)
131. VK Bhatnagar and G Talaska: Carcinogen exposure and effect biomarkers. Toxicol Lett 108, 107-116 (1999)
132. 32P-postlabelling analysis. Carcinogenesis 11, 205-211 (1990)
133. DH Philip, A Hewer, CN Martin, RC Garner and MM King: Correlation of DNA adduct levels in human lung with cigarette smoking. Nature (London) 336, 790-792 (1988)
134. M Rojas, K Alexandrov, G Auburtin, A Wastiaux-Denamur, L Mayer, B Mahieu, P Sebastien and H Bartsch: Anti-benzo[a]pyrene diolepoxide-DNA adducts levels in pheripheral mononuclear cells from coke-oven workers and the enhancing effect of smoking. Carcinogenesis 16, 1373-1376 (1995)
135. T Schettgen, HC Broding, J Angerer and H Drexler: Hemoglobin adducts of ethylene oxide, propylene oxide, acrylonitrile and acrylamide-biomarkers in occupational and environmental medcicine. Toxicol Lett 134, 65-70 (2002)
136. L Hagmar, M Törnnqvist, C Nordander, I Rosen, M Bruze, A Kautiainen, A-L Magnusson, B Malmberg, P Aprea, F Granath and A Axmon: Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of internal dose. Scand J Work Environ Health 27, 291-226 (2001)
137. PJ Boogaard, NJ van Sittert and HJJJ Megens: Urinary metabolites and haemoglobin adducts as biomarkers of exposure to 1,3-butadiene: a basis for 1,3-butadiene cancer risk assessment. Chem-Biol Interactions 135-136, 695-701 (2001)
138. SM Rappaport and K Yeowell-O'Connel: Protein adducts as dosimeters of human exposure to styrene, styrene-7,8-oxide, and benzene. Toxicol Lett 108, 117-126 (1999)
139. C Magagnotti, F Orsi, R Bagnati, N Celli, D Rotilio, R Fanelli and L Airoldi: Effect of diet on serum albumin and hemoglobin adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans. Int J Cancer 88, 1-6 (2000)
140. G Sabbioni: Biological monitoring of arylamines and nitroarenas. In: DFG Biological Monitoring. Prospects in Occupational and Environmental Medicine. Weinheim: Wiley-VCH Verlag, 2002: 24-34.
141. DFG. Biological Monitoring. Prospects in Occupational and Environmental Medicine. Weinheim: Wiley-VCH Verlag, 2002.
142. st ed. Geneva, 1993.
143. rd ed. Geneva, 2000.
144. CEN/CENELEC. European standard EN45001, General criteria for the operation of testing laboratories. Brusssels, Belgium: CEN/CENELEC The Joint European Standards Institution. (1989)
145. K-H Schaller, J Angerer and H Drexler: Quality assurance of biological monitoring in occupational and environmental medicine. J Chromatogr 778, 403-417 (2002)
146. J Angerer, K-H Schaller, eds. Analyses of Hazardous Substances in Biological Materials, Vols. 1 to 6, Weinheim, Germany, 1985-1999.
147. K-H Schaller, J Angerer, G Lehnert, H Valentin and D Welte: External quality control programmes in the toxicological analysis of biological material in the field of occupational medicine-experiences from three round-robins in the Federal Republic of Germany. Fresenius Z Anal Chem 326, 643-646 (1987)
148. K-H Schaller, J Angerer and G Lehnert: Internal and external quality control in the toxicological analysis of blood and urine samples in the federal Republic of Germany. Int Arch Occup Environ Health 62, 537 (1991)
149. K-H Schaller, J Angerer, D Weltle and H Drexler: External Quality Assurance program for biological monitoring in occupational and environmental medicine, Rev Environ Health 16, 223-232 (2001)
150. G Lehnert, K-H Schaller and J Angerer: Report on the status of the external quality control programs for occupational medical and environmental medical toxicological analyses in biological materials in Germany. Int Arch Occup Environ Health 72, 60-64 (1999)
151. R Heinrich-Ramm, G Lehnert and J Angerer: The German external quality assessment scheme in occupational and environmental medicine. Ann Ist Super Sanità 32 (2), 247-251 (1996)
152. S Valkonen, K Engström, I Ahonen., P Mutanen and A Aitio: FIOH external quality assessment scheme for organic solvent metabolites. Ann Ist Super Sanità 32 (2), 225-231 (1996)
153. S Valkonen and A Kallio: Finnish quality assurance program for biological monitoring of organic solvents. Journal of Chromatogr B Analyt Technol Biomed Life Sci 778, 419-427 (2002)
154. D Bullock, N Smith and T Whitehead: External quality assessment assays of lead in blood. Clin Chem 32 (10), 1884-1889 (1986)
155. A Taylor and RJ Briggs: The Guilford trace elements external quality assessment scheme. Ann Ist Super Sanità 32 (2) 253-259 (1996)
156. JM Christiansen and J Kristiansen: The Danish external quality assessment scheme. Ann Ist Super Sanità 32 (2) 221-224 (1996)
157. M Jakubowski, M Trzcinka-Ochocka, T Halatek, G Raźniewska and W Szymczak: Integrated indexes of occupational exposure as predictors of kidney dysfunction. Int J Occup Environ Health, 15, 393-399 (2002)
158. M Ogata, T Numano, M Hosokawa and H Michitsui: Large-scale biological monitoring in Japan. Sci Total Environ, 199, 197-204 (1997)
159. Boogaard PJ. Personal information on establishment of the Shell Biomedical Laboratory. 2004.